R. Xiao and E. Lakatta, Beta 1-adrenoceptor stimulation and beta 2-adrenoceptor stimulation differ in their effects on contraction, cytosolic Ca2+, and Ca2+ current in single rat ventricular cells, Circulation Research, vol.73, issue.2, pp.286-300, 1993.
DOI : 10.1161/01.RES.73.2.286

S. Bartel, E. Krause, G. Wallukat, and P. Karczewski, New insights into ??2-adrenoceptor signaling in the adult rat heart, Cardiovascular Research, vol.57, issue.3, pp.694-703, 2003.
DOI : 10.1016/S0008-6363(02)00720-4

V. Kuznetsov, E. Pak, R. Robinson, and S. Steinberg, ??2-Adrenergic Receptor Actions in Neonatal and Adult Rat Ventricular Myocytes, Circulation Research, vol.76, issue.1, pp.40-52, 1995.
DOI : 10.1161/01.RES.76.1.40

A. Farah, Glucagon and the circulation, Pharmacol Rev, vol.35, pp.181-217, 1983.

J. Hayes, L. Brunton, J. Brown, J. Reese, and S. Mayer, Hormonally specific expression of cardiac protein kinase activity, Proceedings of the National Academy of Sciences, vol.76, issue.4, pp.1570-1574, 1979.
DOI : 10.1073/pnas.76.4.1570

L. Brunton, J. Hayes, and S. Mayer, Hormonally specific phosphorylation of cardiac troponin I and activation of glycogen phosphorylase, Nature, vol.159, issue.5717, pp.78-80, 1979.
DOI : 10.1006/abio.1976.9999

W. Wong and J. Scott, AKAP signalling complexes: focal points in space and time, Nature Reviews Molecular Cell Biology, vol.92, issue.12, pp.959-970, 2004.
DOI : 10.1038/35050030

J. Jurevicius and R. Fischmeister, cAMP compartmentation is responsible for a local activation of cardiac Ca2+ channels by beta-adrenergic agonists., Proceedings of the National Academy of Sciences, vol.93, issue.1, pp.295-299, 1996.
DOI : 10.1073/pnas.93.1.295

M. Zaccolo and T. Pozzan, Discrete microdomains with high concentration of cAMP in Circulation Research Manuscript #CIRCRESAHA124800 -R1 Original Contribution orchestrate signalling cross-talk, desensitization and compartmentalization, Biochem J, vol.370, pp.1-18, 2003.

W. Richter, S. Jin, and M. Conti, Splice variants of the cyclic nucleotide phosphodiesterase PDE4D are differentially expressed and regulated in rat tissue, Biochemical Journal, vol.388, issue.3, pp.803-811, 2005.
DOI : 10.1042/BJ20050030

G. Bolger, A. Mccahill, E. Huston, Y. Cheung, T. Mcsorley et al., The Unique Amino-terminal Region of the PDE4D5 cAMP Phosphodiesterase Isoform Confers Preferential Interaction with ??-Arrestins, Journal of Biological Chemistry, vol.278, issue.49, pp.49230-49238, 2003.
DOI : 10.1074/jbc.M303772200

P. Méry, S. Lohmann, U. Walter, and R. Fischmeister, Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes., Proceedings of the National Academy of Sciences, vol.88, issue.4, pp.1197-1201, 1991.
DOI : 10.1073/pnas.88.4.1197

G. Vandecasteele, I. Verde, C. Rucker-martin, P. Donzeau-gouge, and R. Fischmeister, channel current in human atrial myocytes, The Journal of Physiology, vol.43, issue.2, pp.329-340, 2001.
DOI : 10.1111/j.1469-7793.2001.0329a.x

M. Movsesian, C. Smith, J. Krall, M. Bristow, and V. Manganiello, Sarcoplasmic reticulum-associated cyclic adenosine 5'-monophosphate phosphodiesterase activity in normal and failing human hearts., Journal of Clinical Investigation, vol.88, issue.1, pp.15-19, 1991.
DOI : 10.1172/JCI115272

P. Méry, V. Brechler, C. Pavoine, F. Pecker, and R. Fischmeister, Glucagon stimulates the cardiac Ca2+ current by activation of adenylyl cyclase and inhibition of phosphodiesterase, Nature, vol.10, issue.6271, pp.158-161, 1990.
DOI : 10.1038/345158a0

M. Lohse, S. Engelhardt, and T. Eschenhagen, What Is the Role of ??-Adrenergic Signaling in Heart Failure?, Circulation Research, vol.93, issue.10, pp.896-906, 2003.
DOI : 10.1161/01.RES.0000102042.83024.CA

C. Smith, R. Huang, D. Sun, S. Ricketts, C. Hoegler et al., Development of Decompensated Dilated Cardiomyopathy Is Associated With Decreased Gene Expression and Activity of the Milrinone-Sensitive cAMP Phosphodiesterase PDE3A, Circulation, vol.96, issue.9, pp.3116-3123, 1997.
DOI : 10.1161/01.CIR.96.9.3116

N. Sato, K. Asai, S. Okumura, G. Takagi, R. Shannon et al., Mechanisms of desensitization to a PDE inhibitor (milrinone) in conscious dogs with heart failure, Am J Physiol, vol.276, pp.1699-1705, 1999.

B. Ding, J. Abe, H. Wei, Q. Huang, R. Walsh et al., Functional Role of Phosphodiesterase 3 in Cardiomyocyte Apoptosis: Implication in Heart Failure, Circulation, vol.111, issue.19, pp.2469-2476, 2005.
DOI : 10.1161/01.CIR.0000165128.39715.87

K. Takahashi, T. Osanai, T. Nakano, M. Wakui, and K. Okumura, Enhanced activities and gene expression of phosphodiesterase types 3 and 4 in pressure-induced congestive heart failure, Heart and Vessels, vol.16, issue.6, pp.249-256, 2002.
DOI : 10.1007/s003800200032

S. Lehnart, X. Wehrens, S. Reiken, S. Warrier, A. Belevych et al., Phosphodiesterase 4D Deficiency in the Ryanodine-Receptor Complex Promotes Heart Failure and Arrhythmias, Cell, vol.123, issue.1, pp.25-35, 2005.
DOI : 10.1016/j.cell.2005.07.030

W. Thompson and M. Appleman, Multiple cyclic nucleotide phosphodiesterase activities from rat brain, Biochemistry, vol.10, pp.311-317, 1971.

N. Oki, S. Takahashi, H. Hidaka, and M. Conti, Short Term Feedback Regulation of cAMP in FRTL-5 Thyroid Cells. ROLE OF PDE4D3 PHOSPHODIESTERASE ACTIVATION, Journal of Biological Chemistry, vol.275, issue.15, pp.10831-10838, 2000.
DOI : 10.1074/jbc.275.15.10831

J. Harper and G. Brooker, Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution, J Cyclic Nucleotide Res, vol.1, pp.207-225, 1975.

A. Steiner, A. Pagliara, L. Chase, and D. Kipnis, Radioimmunoassay for cyclic nucleotides. II. Adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in mammalian tissues and body fluids, J Biol Chem, vol.247, pp.1114-1134, 1972.